Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853
Shareholders' deficiency, beginning balance	$ (745,020)	$ (678,551)
Net loss	$ (90,485)	$ (66,469)
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ (835,505)	$ (745,020)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, beginning balance	$ 1,233	$ 1,233
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	81,323	81,323
Shareholders' deficiency, ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	(827,576)	(761,107)
Net loss	(90,485)	(66,469)
Shareholders' deficiency, ending balance	$ (918,061)	$ (827,576)